Danting Zhu

发表

Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis

A. Paller, K. Papp, J. Cather, 2022, JAMA dermatology.

Safety of ixekizumab in patients with psoriatic arthritis: data from four clinical trials with over 2000 patient-years of exposure

G. Burmester, A. Deodhar, B. Combe, 2022, Annals of the Rheumatic Diseases.

Baseline Characteristics and Treatment Response to Ixekizumab Categorised by Sex in Radiographic and Non-radiographic Axial Spondylarthritis Through 52 Weeks: Data from Three Phase III Randomised Controlled Trials

E. Soriano, M. Magrey, J. Walsh, 2022, Advances in Therapy.

Safety of Ixekizumab in Adult Patients with Moderate-to-Severe Psoriasis: Data from 17 Clinical Trials with Over 18,000 Patient-Years of Exposure

C. Griffiths, M. Gooderham, A. Blauvelt, 2022, Dermatology and Therapy.

16S rDNA analysis of periodontal plaque in chronic obstructive pulmonary disease and periodontitis patients

Wenhong Zhang, Jing Wu, Jiazhen Chen, 2017, Journal of oral microbiology.

Ixekizumab Citrate-Free Formulation: Results from Two Clinical Trials

L. Puig, G. Gallo, C. Pitou, 2022, Advances in Therapy.

Microbiota in Human Periodontal Abscess Revealed by 16S rDNA Sequencing

Wenhong Zhang, Jiazhen Chen, Danting Zhu, 2019, Front. Microbiol..

AdipoRon accelerates bone repair of calvarial defect in diet-induced obesity mice

Q. Tu, J. Chen, Danting Zhu, 2023, Heliyon.